What is the clinical evidence from this study?

Study design: Other. Population: Drug-induced QTc prolongation.

January 1, 2005

Cardiac safety of noncardiac drugs : practical guidelines for clinical research and drug development

View Full Paper

Ask AI

Bookmark

Design

Guideline

Authors

JMJoel MorganrothClarion University IGIhor GussakRutgers, The State University of New Jersey

Discussion

Member takes

Implication

Enables consistent cardiac risk evaluation in trials; extends prior standards to current noncardiac drug development.

PICO

Population

Drug-induced QTc prolongation

This document provides comprehensive guidelines and methodologies for assessing the cardiac safety, specifically QT prolongation and arrhythmogenesis, of noncardiac drugs during clinical research and drug development.

Cite This Study

Morganroth et al. (2005) studied Drug-induced QTc prolongation. This publication is a textbook providing practical guidelines for assessing the cardiac safety of noncardiac drugs in clinical research and drug development.

synapsesocial.com/papers/6a94493b893ee072278c2802 https://doi.org/10.1007/978-1-59259-884-7

View Full Paper

Ask AI

Bookmark

Cardiac safety of noncardiac drugs : practical guidelines for clinical research and drug development

Discussion

Member takes

Implication

PICO

Cite This Study

Cardiac safety of noncardiac drugs : practical guidelines for clinical research and drug development

Discussion

Member takes

Implication

PICO

Cite This Study

Also Consider

Also Consider